Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - calcium chloride dihydrate 10%;  ;   - solution for injection - 10% w/v - active: calcium chloride dihydrate 10%     excipient: calcium hydroxide hydrochloric acid water for injection as co2 free as possible - for the immediate treatment of hypocalcaemic tetany. other therapy such as parathyroid hormone and/or vitamin d may be indicated depending on the aetiology of the tetany. oral calcium should be substituted as soon as possible. calcium salts may be used as adjunctive therapy in severe hyperkalaemia or as an aid in the treatment of depression due to overdosage of magnesium sulphate (calcium is the antagonist of magnesium toxicity). calcium chloride is occasionally used as an inotrope in cardiac resuscitation.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - calcium chloride dihydrate 148 mg/ml;   - solution for injection - 740 mg/5ml - active: calcium chloride dihydrate 148 mg/ml   excipient: hydrochloric acid water for injection

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 6 mg/ml; calcium chloride dihydrate, quantity: 0.27 mg/ml; potassium chloride, quantity: 0.4 mg/ml; sodium lactate, quantity: 3.12 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as a solvent for intravenously administrated drugs where compatibility has been established. compound sodium lactate is particularly suitable for the replacement of extracellular fluid loss when isotonic dehydration is evident and in burn therapy.

Ísrael - enska - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; calcium chloride dihydrate 0.184 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 38.6 g/l; lactic acid as sodium 1.68 g/l - calcium chloride - calcium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure; severe water retention; severe electrolyte imbalance; drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - calcium chloride dihydrate - solution for injection - 100mg/1ml

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - calcium chloride dihydrate - solution for injection - 147mg/1ml

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - calcium chloride dihydrate - solution for injection - 147mg/1ml

Malta - enska - Malta Medicines Authority

martindale pharmaceuticals limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - calcium chloride, dihydrate - solution for injection - calcium chloride dihydrate 7.35 % (w/v) - blood substitutes and perfusion solutions

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis, and/or automated peritoneal dialysis. can also be used for acute renal failure.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 15 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis, and/or automated peritoneal dialysis. can also be used for acute renal failure.